ONDANSETRON HYDROCHLORIDE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency, specifically the DLA Troop Support Medical Supply Chain FSB, issued delivery order SPE2D226F3519 on September 15, 2026. This order was awarded to DMS Pharmaceutical Group Inc for the procurement of Ondansetron Hydrochloride Injection, identified by NSN 6505015786170 and PR 7018361758. The total price for this specific award is 21.00 dollars, and the supplies are designated for delivery to the USS Roosevelt (DDG 80). This delivery order operates under the broader administrative base contract SPE2DX25D9822, which itself falls under base contract SPE2DX25D9000. The primary base contract was established on March 7, 2025, with a total award value of 20,000,000 dollars. The transaction is managed as a federal organization procurement within the Department of Defense.
General Info
Contract Value
$21Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
